VONLEROLIZUMAB

Investigational

Approval Year

Name

Type

Language

POGALIZUMAB

Preferred Name

English

VONLEROLIZUMAB

Official Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4(TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 (ACT35 ANTIGEN, OX40L RECEPTOR, CD134 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED MOUSE VH (HOMO SAPIENS IGHV1-46*01 (81%)

Systematic Name

English

R0-7021608

Code

English

Vonlerolizumab [WHO-DD]

Common Name

English

RG7888

Code

English

vonlerolizumab [INN]

Common Name

English

MOXR-0916

Code

English

R07021608

Code

English

RG-7888

Code

English

MOXR0916

Code

English

VONLEROLIZUMAB [USAN]

Common Name

English

Code System Code Type Description

CAS

1638935-72-4